Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
13F holders, Q3 2024
Institutional positions in Psyence Biomedical Ltd. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −5 vs. Q2 2024
- Shares held
- 6.29M
- −296.8K (−4.5%) vs. Q2 2024
- Total value
- $79.2K
- +$7.35K (+10.2%) vs. Q2 2024
- New holders
- 0
- 2 more added
- Sold out
- 5
- 1 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBMWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $121.6K |
| Q1 2026 | 19 | $96.6K |
| Q4 2025 | 21 | $101.1K |
| Q3 2025 | 23 | $142.4K |
| Q2 2025 | 23 | $123.8K |
| Q1 2025 | 23 | $96.4K |
| Q4 2024 | 22 | $80.2K |
| Q3 2024 | 23 | $79.2K |
| Q2 2024 | 28 | $71.9K |
| Q1 2024 | 30 | $499.9K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Psyence Biomedical Ltd.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cowen and Company, LLC | 1,220,986 | $15.4K | 0.00% | +51,780+4.4% | Added |
| Polar Asset Management Partners Inc. | 733,000 | $9.24K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 600,000 | $7.56K | 0.00% | 00.0% | Unchanged |
| Calamos Advisors LLC | 500,000 | $6.35K | 0.00% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 468,500 | $5.90K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 297,847 | $3.75K | 0.00% | 00.0% | Unchanged |
| Clear Street Derivatives LLC | 277,919 | $3.50K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 272,857 | $3.10K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 234,200 | $2.95K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 225,000 | $2.83K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 200,117 | $2.52K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 198,296 | $2.50K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 180,426 | $2.27K | 0.00% | +150+0.1% | Added |
| D. E. Shaw & Co., Inc. | 175,352 | $2.23K | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 150,000 | $1.89K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 148,809 | $1.88K | 0.00% | −26,191−15.0% | Reduced |
| Wolverine Asset Management LLC | 147,101 | $1.85K | 0.00% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 92,073 | $1.17K | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 50,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 76,843 | $968 | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 24,354 | $307 | 0.00% | 00.0% | Unchanged |
| Ancora Advisors, LLC | 5,000 | $63 | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 12,500 | – | – | 00.0% | Unchanged |
| LMR Partners LLP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Flow State Investments, L.P. | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Whitebox Advisors LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| SkyView Investment Advisors, LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |